Study Restart CRF Study Description YouTHrive (YT) was a two-arm randomized control trial (RCT) that tested the efficacy of an adapted version of the Thrive With Me (TWM) intervention for youth living
The global sickle cell disease treatment market size is expected to reach USD 6.94 billion by 2030, according to a new study by Polaris Market Research.
Previous studies report that metformin triggers fetal hemoglobin (HbF) induction in human erythroid cells through indirect activation of the AMPK/FOXO3 pathway. Here we investigated the underlying mec
We have investigated gene expression changes occurring in samples transduced with a lentiviral vector expressing the βAS3m transgene and the miR7m targeting the sickle β-globin Overall design: We perf